0001855833-21-000004.txt : 20210419 0001855833-21-000004.hdr.sgml : 20210419 20210419170029 ACCESSION NUMBER: 0001855833-21-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210419 DATE AS OF CHANGE: 20210419 EFFECTIVENESS DATE: 20210419 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RxE2 Inc. CENTRAL INDEX KEY: 0001855833 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-396332 FILM NUMBER: 21835253 BUSINESS ADDRESS: STREET 1: 4302 13TH AVE S, STE. 4326 CITY: FARGO STATE: ND ZIP: 58103 BUSINESS PHONE: 701-361-7650 MAIL ADDRESS: STREET 1: 4302 13TH AVE S, STE. 4326 CITY: FARGO STATE: ND ZIP: 58103 D 1 primary_doc.xml X0708 D LIVE 0001855833 RxE2 Inc. 4302 13TH AVE S, STE. 4326 FARGO ND NORTH DAKOTA 58103 701-361-7650 DELAWARE None None Corporation true 2021 Gerald E. Finken 4302 13TH AVE S, STE. 4326 Fago ND NORTH DAKOTA 58103 Executive Officer Director Chief Executive Officer, Chief Financial Officer and Secretary Other Decline to Disclose 06b false 2021-03-31 true true true 2021 Equity Incentive Plan false 0 1 0 1 false 0 0 0 0 false RxE2 Inc. /s/ Gerald E. Finken Gerald E. Finken CEO 2021-04-19